Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

11 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +45 more
Locations
  • UC Irvine/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Completed

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

NCT01345019

Conditions
Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, +34 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Fayetteville, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Campbell, California, United States
View all 309 locations
View Trial Details
Completed

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

NCT01844765

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Lucile Salter Packard Children's Hospital at Stanford Palo Alto, California, United States
  • Nemours Childrens Hospital Orlando, Florida, United States
  • St. Mary's Hospital West Palm Beach, Florida, United States
View all 36 locations
View Trial Details
Completed

Fractionated Radiosurgery for Painful Spinal Metastases

NCT01594892

Conditions
Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasm, Residual, +7 more
Locations
  • Leopoldina Schweinfurt Schweinfurt, Germany
  • Department of Radiation Oncology, University of Wuerzburg Würzburg, Germany
  • Netherlands Cancer Institute Amsterdam, Netherlands
  • University Hospital Zurich Zurich, Switzerland
View Trial Details
Completed

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

NCT01386580

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +33 more
Locations
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Jules Bordet Institute Brussels, Belgium
  • Institut Curie Paris, Paris Cedex 05, France
View Trial Details

Related conditions